Outcome of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with systemic therapy without cytoreductive nephrectomy (CN)

被引：0
|
作者：
Richey, S. L. [1 ]
Culp, S. H. [1 ]
Wood, C. G. [1 ]
Corn, P. G. [1 ]
Jonasch, E. [1 ]
Tannir, N. M. [1 ]
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16035
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Cytoreductive nephrectomy in metastatic renal cell carcinoma: outcome of patients treated with a multidisciplinary, algorithm-driven approach
    Liu, Wing K.
    Lam, J. M.
    Butters, T.
    Grant, M.
    Jackson-Spence, F.
    Bex, A.
    Powles, T.
    Szabados, B.
    WORLD JOURNAL OF UROLOGY, 2020, 38 (12) : 3199 - 3205
  • [32] CABOPRE: Phase II study of cabozantinib prior to cytoreductive nephrectomy (CN) in locally advanced and/or metastatic renal cell carcinoma (mRCC).
    de Velasco, Guillermo
    Gonzalez, Borja
    Alonso, Teresa
    Pinto, Alvaro
    Francisco Rodriguez-Moreno, Juan
    Manuel Sepulveda, Juan
    Carlos Villa, Jose
    Miranda, Natalia
    Guerrero, Felix
    Castellano, Daniel E.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] Temporal trends and socioeconomic determinants of cytoreductive nephrectomy (CN) utilization for metastatic renal cell carcinoma (mRCC) in the United States (US).
    Esagian, Stepan M.
    Msaouel, Pavlos
    Karam, Jose A.
    Gartrell, Benjamin
    Makrakis, Dimitrios
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [34] The role of cytoreductive nephrectomy (CN) for patients with metastatic renal cell carcinoma (mRCC) in the setting of retroperitoneal lymphadenopathy: An analysis of the National Cancer Database (NCDB)
    Reddy, Akshay
    Sparks, Andrew D.
    Whalen, Michael Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [35] Immediate versus deferred cytoreductive nephrectomy (CN) in patients with synchronous metastatic renal cell carcinoma (mRCC) receiving sunitinib (EORTC 30073 SURTIME)
    Bex, A.
    Mulders, P.
    Jewett, M. A. S.
    Wagstaff, J.
    van Velthoven, R.
    Pes, P. M. Laguna
    Wood, L.
    van Melick, H. H. E.
    Soetekouw, P.
    Lattouf, J. B.
    Powles, T.
    Boleti, E.
    de Jong, I-J.
    Rottey, S.
    Tombal, B.
    Marreaud, S.
    Collette, L.
    Collette, S.
    Blank, C. U.
    Haanen, J. B.
    ANNALS OF ONCOLOGY, 2017, 28
  • [36] Outcome of octogenarian versus (vs) young patients (pts) with metastatic renal cell carcinoma (mRCC), treated with sunitinib (su).
    Kushnir, Igal
    Rosenbaum, Eli
    Sarid, David Leonid
    Sella, Avishay
    Gottfried, Maya
    Maimon, Natalie
    Peer, Avivit
    Neumann, Avivit
    Neiman, Victoria
    Kovel, Svetlana
    Gez, Eliahu
    Mermershtain, Wilmosh
    Rouvinov, Keren
    Carducci, Michael Anthony
    Eisenberger, Mario A.
    Hammers, Hans J.
    Sinibaldi, Victoria J.
    Berger, Raanan
    Keizman, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [37] NLR as prognostic biomarker for metastatic renal cell carcinoma patients treated with cytoreductive nephrectomy
    Liu, Huanrui
    Li, Senlin
    Zhang, Fan
    He, Weiyang
    Gou, Xin
    Zhang, Xu
    Xie, Yongpeng
    BIOMARKERS IN MEDICINE, 2025,
  • [38] Outcome of octogenarian versus (vs) young patients (pts) with metastatic renal cell carcinoma (mRCC), treated with sunitinib (su).
    Kushnir, Igal
    Rosenbaum, Eli
    Sella, Avishay
    Sarid, David
    Gottfried, Maya
    Maimon, Natalie
    Peer, Avivit
    Neumann, Avivit
    Neiman, Victoria
    Kovel, Svetlana
    Gez, Eliahu
    Mermershtain, Wilmosh
    Rouvinov, Keren
    Carducci, Michael Anthony
    Eisenberger, Mario A.
    Hammers, Hans J.
    Sinibaldi, Victoria J.
    Berger, Raanan
    Keizman, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [39] NLR as prognostic biomarker for metastatic renal cell carcinoma patients treated with cytoreductive nephrectomy
    Liu, Huanrui
    Li, Senlin
    Zhang, Fan
    He, Weiyang
    Gou, Xin
    Zhang, Xu
    Xie, Yongpeng
    BIOMARKERS IN MEDICINE, 2025, 19 (06) : 215 - 222
  • [40] The role of cytoreductive nephrectomy and systemic therapy in the management of tumor thrombus in patients with metastatic renal cell carcinoma.
    Mittal, Abhenil
    Al-Ezzi, Esmail Mutahar
    Li, Xuan
    Wilson, Brooke
    Spiliopoulou, Pavlina
    Sridhar, Srikala S.
    Fallah-Rad, Nazanin
    Chung, Peter W. M.
    Hamilton, Robert James
    Hansen, Aaron Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
12345